Maike Janssen

Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1

Maike Janssen, Christina Schmidt, Peter‐Martin Bruch et al. · Blood · 2022 · 93 citations · Full text

Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia

Sergi Beneyto‐Calabuig, Anne Kathrin Merbach, Jonas-Alexander Kniffka et al. · Cell stem cell · 2023 · 87 citations · Full text

Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax

Alexander Waclawiczek, Aino‐Maija Leppä, Simon Renders et al. · Cancer Discovery · 2023 · 85 citations · Full text

Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response

Marina Scheller, Anne K. Ludwig, Stefanie Göllner et al. · Nature Cancer · 2021 · 69 citations

Hematological Malignancy, Chromatin, Hotspot Dnmt3a Mutations +9

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel et al. · Nature Cancer · 2022 · 62 citations · Full text